Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

For example, about 44% of individuals in each treatment arm experienced nausea and 25% ... compared with 16% of those who received semaglutide. The improved performance is likely linked to ...

Weight loss injections could be available in Northern Ireland on the health service, after the first regional obesity ...

The prospect of reducing the risk of some very common cancers adds the weight of evidence behind the GLP-1 agonist class, ...

Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

When multibillion-pound global corporations invest huge sums in medical companies to develop new treatments for serious ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...